FitLife Brands, Inc. 2020 Form 10-K Summary
Reporting period: Fiscal year ended December 31, 2020, with comparative results for 2019. The filing was signed March 26, 2021. FitLife develops and distributes nutritional supplements under NDS and iSatori brands through GNC, specialty and mass retailers, and direct-to-consumer e-commerce channels.
Financial Performance and Liquidity
| Metric | 2020 | 2019 | Change |
|---|---|---|---|
| Revenue | $21.744 million | $19.497 million | +12% |
| Gross profit | $9.394 million | $8.061 million | +17% |
| Gross margin | 43.2% | 41.3% | +190 bps |
| Operating income | $4.204 million | $2.581 million | +63% |
| Net income | $8.714 million | $2.698 million | +223% |
| Diluted EPS | $7.66 | $2.41 | +218% |
| Cash flow from operations | $5.721 million | $2.261 million | +153% |
| Adjusted EBITDA | $4.390 million | $2.986 million | +47% |
- Derived margins were approximately 19.3% for operating income and 40.1% for net income in 2020. Net income was substantially affected by a $4.370 million income tax benefit from releasing most of the valuation allowance on deferred tax assets.
- Online revenue increased to approximately 20% of total revenue from approximately 12% in 2019. Management attributed growth to improved wholesale sales, direct-to-consumer expansion, and increased online purchasing during COVID-19.
- Cash increased to $6.336 million from $265,000, while working capital increased to $7.744 million from $2.925 million. Accounts receivable were $2.044 million and inventory was $3.401 million at year-end.
- The Company had no balance outstanding under its $2.5 million secured revolving line of credit at December 31, 2020. It temporarily drew the full facility on March 20, 2020 and repaid it on April 29, 2020. The maturity date was extended to September 23, 2021.
- The Company received a $449,700 PPP loan at 1% interest. The balance, including accrued interest, was forgiven on January 15, 2021. The balance reported at December 31, 2020 was $453,000.
- Total liabilities were $4.740 million and stockholders’ equity was $12.034 million at December 31, 2020. No material capital expenditures or investing cash flows were reported.
Material Changes Versus 2019
- Revenue growth and a greater mix of higher-margin direct-to-consumer sales increased gross margin from 41.3% to 43.2%.
- Selling and marketing expense declined 12% to $2.105 million, primarily because COVID-19 reduced travel expenses. General and administrative expense was essentially unchanged.
- Operating income rose 63% to $4.204 million, while adjusted EBITDA increased 47% to $4.390 million.
- Net income growth was amplified by the $4.370 million deferred tax benefit; the filing indicates this benefit was not an operating revenue or cash-flow item.
- GNC remained the dominant customer, representing 71% of 2020 revenue versus 75% in 2019. GNC-related receivables represented 89% of total receivables at year-end.
- The Company introduced 32 products in 2020, including 12 new products and 20 reformulations or flavor extensions, compared with 11 total product introductions in 2019.
- The Company repurchased 11,900 common shares for approximately $171,000 during 2020. In February 2021, the authorized repurchase program was increased to $5.0 million.
Outlook, Commentary, Risks, and Unusual Items
- Management expects online revenue to continue increasing relative to prior periods, at least through most of 2021, and intends to focus on higher-margin online sales. No quantitative revenue or earnings guidance was provided.
- Management stated that cash from operations, existing cash, and available revolver borrowings are expected to support liquidity for the next twelve months, while acknowledging that this is not assured.
- Management noted that some fourth-quarter 2020 wholesale purchases may have been accelerated from the first quarter of 2021, creating a potential timing risk.
- COVID-19 temporarily closed or restricted some retail partner locations and negatively affected operations, although online sales and stronger later-quarter sales offset much of the impact. A resurgence could reduce demand or disrupt suppliers, manufacturing lead times, and deliveries.
- Product returns, sales incentives, and related reserves are material estimates. The product-return liability was $335,000 at year-end, compared with $256,000 in 2019. Product returns were estimated at less than 5% of products sold.
- The independent auditor identified product-return estimates and realizability of deferred tax assets as critical audit matters. The deferred tax asset was $4.370 million after releasing substantially all of the prior valuation allowance.
- Principal business risks include customer concentration at GNC, competition, reliance on third-party manufacturers and suppliers, regulatory requirements for dietary supplements and advertising claims, product liability and recalls, changing consumer demand, key-person dependence, and limited OTC trading liquidity.
- The Company reported no material pending litigation and no material off-balance-sheet arrangements. Its Omaha lease has approximately $208,000 of present-value liabilities and is scheduled to expire in May 2024.
- The Company adopted a tax benefits preservation plan in February 2021 intended to protect its net operating losses from an ownership change under Internal Revenue Code Section 382.
Investor Verification Points
- Verify the sustainability of 2020 operating performance excluding the $4.370 million deferred tax benefit and assessing the effect of potential wholesale order acceleration.
- Monitor GNC purchasing levels and receivable concentration, given that GNC represented 71% of revenue and 89% of year-end accounts receivable.
- Assess whether online growth and higher-margin direct-to-consumer sales continue after pandemic-related retail disruptions subside.
- Review product-return reserves, inventory levels, vendor-funded discounts, and supply-chain capacity, particularly in light of the auditor’s critical audit matter.
- Confirm the final accounting and tax treatment of the forgiven PPP loan and the continued realizability of deferred tax assets and remaining NOLs.
- Evaluate the secured revolver’s availability, maturity, covenants, and interest-rate exposure after September 23, 2021.
- Consider dilution and governance implications from outstanding options and warrants, the expanded repurchase authorization, concentrated voting control, and the tax benefits preservation plan.